NextStage Clinical Research-Chicago-(04) — Lisle, Illinois

NextStage Clinical Research-Chicago-(04) is a clinical research site located in Lisle, Illinois, United States 60532.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NextStage Clinical Research-Chicago-(04) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Castrate Resistant Prostate Cancer (mCRPC).

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NextStage Clinical Research-Chicago-(04)?

NextStage Clinical Research-Chicago-(04) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NextStage Clinical Research-Chicago-(04) conducted?

NextStage Clinical Research-Chicago-(04) has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Castrate Resistant Prostate Cancer (mCRPC).

Is NextStage Clinical Research-Chicago-(04) accredited by Crixeo Health?

NextStage Clinical Research-Chicago-(04) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NextStage Clinical Research-Chicago-(04)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.